SHAWNTEL PRICE: Open Payments
NPI 1164882700 · MAGNOLIA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 28 payments from 11 companies in 2025. Trend: 2023 $1,317 · 2024 $1,124 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Alkermes, Inc. | 1 | $79 |
| ABBVIE INC. | 4 | $65 |
| Abbott Laboratories | 2 | $46 |
| Novo Nordisk Inc | 3 | $44 |
| Lilly USA, LLC | 2 | $38 |
| PFIZER INC. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: TRINTELLIX, VIVITROL, BREZTRI, QULIPTA, FREESTYLE LIBRE 3, Rybelsus, ONZETRA XSAIL, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
